未破裂型输卵管妊娠治疗后输卵管通畅性研究  

Study on tubal patency after treatment of unruptured tubal pregnancy

作　　者：黄立冬[1] 

机构地区：[1]广西壮族自治区人民医院妇产科,广西壮族自治区南宁530021

出　　处：《中国基层医药》2008年第9期1428-1429,共2页Chinese Journal of Primary Medicine and Pharmacy

摘　　要：目的利用子宫输卵管造影术评价未破裂型输卵管妊娠经治疗后输卵管再通情况。方法80例确诊为输卵管型妊娠的妇女，其中30例采用甲氨蝶呤50mg／m^2肌注，药物治疗后1～3个月，利用子宫输卵管造影术了解输卵管再通情况，为治疗组；其余50例确诊后仅给予期待疗法，治疗后1～3个月，利用子宫输卵管造影术了解输卵管再通情况，为对照组。结果治疗组经甲氨蝶呤治疗后同侧及对侧输卵管通畅率分别为84％和97％，对照组同侧及对侧输卵管通畅率分别为78％和92％，两组间比较差异无统计学意义。结论未破裂型输卵管妊娠可以选择期待疗法或注射甲氨蝶呤治疗，两者的输卵管再通率相似。Objective To evaluate tubal patency by hysterosalpingography after treatment of tubal pregnancy. Methods 80 patients with tubal pregnancy underwent hysterosalpingography after clinical treatment. Of them,30 were treated with methotrexate of 50mg/m^2 intramuscularly （study group, n = 30） and 50 were followed up expectantly （control group,n = 50）. Results Ipsilateral and contralateral tubal patencies in the study group were 84% and 97% ,respectively,whereas in the control group were 78% and 92%, respectively. There were no statistically significant differences between the two groups. Conclusion Appropriate options for unruptured tubal pregnancy includes either expectant management or methotrexate treatment,both of which result in similar tubal patency rate.

关 键 词：妊娠 输卵管 期待疗法 甲氨蝶呤 子宫输卵管造影术 

分 类 号：R714[医药卫生—妇产科学]